Amazon One Medical expanded access to its AI-powered health assistant, allowing anyone on the Amazon website or app to ask medical questions, interpret lab results and connect to care if needed. The chatbot reflects a broader trend of AI becoming a first stop for Americans navigating the healthcare system. The post Amazon One Medical CMO:…
Vima Therapeutics is expanding to Parkinson’s disease following early clinical results showed proof of concept for its drug in isolated dystonia, a rare neurological movement disorder. The startup says its drug could address the biology underpinning many movement disorders. The post Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M…
Through a new partnership, Carrum Health can refer patients to Virta Health for weight management support, while Virta can refer patients to Carrum for surgical care. The post Carrum, Virta Join Forces on Employer Weight Management Solution appeared first on MedCity News.
Healthcare is pouring money into AI, but poor data quality is quietly sabotaging results by scaling bias, errors, and mistrust instead of value. Until organizations fix historical data, set accuracy baselines, and keep humans in the loop, AI will multiply problems faster than it improves outcomes. The post Artificial Intelligence and the Data Quality Problem…
When healthcare staff feel unsafe, they are more likely to feel overwhelmed and distracted, increasing their risk of error. This directly links provider safety to patient safety. The post Why Staff Safety is the Foundation of Clinical Excellence appeared first on MedCity News.
Nitra announced that it raised $187 million in the past six months. The AI-powered platform — which is now used by more than 700 clinics — manages payments, procurement, inventory, scheduling and insurance verification in a single platform. The post Nitra Rakes In $187M to Simplify the Business of Running a Healthcare Practice appeared first…
Universal Health Services plans to acquire Talkspace for $835 million to create a national behavioral health platform that integrates virtual therapy with in-person care. The post Why UHS Is Acquiring Talkspace for $835M appeared first on MedCity News.
Povetacicept, a Vertex Pharmaceuticals immunology drug designed to block two targets, met the main goal of a Phase 3 clinical trial in the rare kidney disease immunoglobulin A nephropathy. The fusion protein came from Vertex’s acquisition of Alpine Immune Sciences, and analysts say the drug has best-in-class potential. The post Vertex Pharma to Seek Speedy…
Polypharmacy is a cost and safety problem that is solvable. The right technology platform can reduce it by identifying risky regimens, route specific “stop/switch/consolidate” opportunities to clinicians, and track whether changes stick through refill and adherence patterns. The post Chronic Overmedication: The Polypharmacy Waste and Safety Problem appeared first on MedCity News.
The way we measure ALS progression is failing patients. We are entering a new era of ALS therapeutics but still relying on the same blunt instruments of measurement. The post In the Absence of Objective Measures for ALS, Caregivers are the Only Witnesses. We Shouldn’t Have To Be. appeared first on MedCity News.